# Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers

> **NCT06680856** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ospedale Policlinico San Martino** · enrollment: 72 (actual)

## Conditions studied

- Diabetic Foot Ulcer
- Skin Lesions
- Allogeneic
- PRP

## Interventions

- **COMBINATION_PRODUCT:** PRP+HA
- **COMBINATION_PRODUCT:** HA

## Key facts

- **NCT ID:** NCT06680856
- **Lead sponsor:** Ospedale Policlinico San Martino
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-23
- **Primary completion:** 2024-10-17
- **Final completion:** 2024-10-17
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-11-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06680856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06680856, "Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06680856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*